<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000658818"><TermName>insulin glargine recombinant</TermName><TermPronunciation>(IN-suh-lin GLAR-jeen ree-KOM-bih-nunt)</TermPronunciation><TermDefinition><DefinitionText>A drug used to control the amount of sugar in the blood of patients with diabetes. It is a form of the hormone insulin that is made in the laboratory. Insulin glargine recombinant controls blood sugar longer than insulin does. It is a type of therapeutic insulin. Also called insulin glargine and Lantus.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726134" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;insulin glargine recombinant&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726135" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;insulina glargina genotecnológica&quot;" language="es" id="_4"/><SpanishTermName>insulina glargina genotecnológica</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para controlar la cantidad de azúcar en la sangre de pacientes de diabetes. Es una forma de la hormona insulina que se produce en el laboratorio. La insulina glargina genotecnológica controla el azúcar sanguíneo durante más tiempo que la insulina. Es un tipo de insulina terapéutica. También se llama insulina garglina y Lantus.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-03-30</DateFirstPublished></GlossaryTerm>
